Researchers have found that an existing diabetes drug can be used to halt progression of another disease that is a leading cause of liver transplants. A three-year clinical trial led by University of ...
Share on Pinterest New research indicates a drug used to treat type 2 diabetes may help lower the risk of dementia. Fertnig/Getty Images Researchers are saying the drug pioglitazone may help reduce ...
An older diabetes drug may help lower the risk for dementia in older people with new-onset type 2 diabetes, a Korean study suggested. Among more than 91,000 newly-diagnosed diabetes patients ages 50 ...
NEW YORK (Reuters) - The high-profile experimental once-weekly injectable diabetes drug from Amylin Pharmaceuticals Inc and Eli Lilly and Co proved superior to the widely used medicines Actos and ...
Please provide your email address to receive an email when new articles are posted on . Patients with metformin-uncontrolled type 2 diabetes taking insulin and pioglitazone had greater risk for ...
CHICAGO (AP) -- The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it ...
Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over ...
* Better blood sugar lowering, weight loss with exenatide * 66 pct reach A1C target, vs 56 for Actos, 42 for Januvia By Bill Berkrot NEW YORK, June 6 (Reuters) - The high-profile experimental ...
CHICAGO - The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results